These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. The role of MAO in dopaminergic transmission. Riederer P, Konradi C, Youdim MB. Adv Neurol; 1990; 53():149-53. PubMed ID: 2173368 [No Abstract] [Full Text] [Related]
9. [Characteristics of the disordered regulation of monoamine oxidase activity in pathological states and the regulatory role of the monoamine oxidases]. Gorkin VZ. Vestn Akad Med Nauk SSSR; 1986; (8):8-13. PubMed ID: 3532612 [No Abstract] [Full Text] [Related]
10. Diminished activity of platelet monoamine oxidase in Down's syndrome. Benson PF, Southgate J. Arch Dis Child; 1970 Oct; 45(243):714. PubMed ID: 4249052 [No Abstract] [Full Text] [Related]
12. [Neurochemical perspectives of the function of monoamine oxidases]. Riederer P, Konradi C, Hebenstreit G. Psychiatr Prax; 1989 Aug 01; 16 Suppl 1():7-10. PubMed ID: 2685857 [Abstract] [Full Text] [Related]
13. Ageing, monoamines, and monoamine-oxidase levels. Robinson DS, Nies A, Davis JN, Bunney WE, Davis JM, Colburn RW, Bourne HR, Shaw DM, Coppen AJ. Lancet; 1972 Feb 05; 1(7745):290-1. PubMed ID: 4109932 [No Abstract] [Full Text] [Related]
14. Diminished activity of platelet monoamine oxidase in Down's syndrome. Benson PF, Southgate J. Am J Hum Genet; 1971 Mar 05; 23(2):211-4. PubMed ID: 4253914 [No Abstract] [Full Text] [Related]
15. Platelet monoamine oxidase B activity in parkinsonian patients. Bonuccelli U, Piccini P, Del Dotto P, Pacifici GM, Corsini GU, Muratorio A. J Neurol Neurosurg Psychiatry; 1990 Oct 05; 53(10):854-5. PubMed ID: 2266365 [Abstract] [Full Text] [Related]
17. Monoamine oxidase inhibitors: promising therapeutic agents for Alzheimer's disease (Review). Cai Z. Mol Med Rep; 2014 May 05; 9(5):1533-41. PubMed ID: 24626484 [Abstract] [Full Text] [Related]
18. Brain and platelet monoamine oxidase in mental disorders 1. Schizophrenics and cycloid psychotics. Eckert B, Gottfries CG, Von Knorring L, Oreland L, Wiberg A, Winblad B. Prog Neuropsychopharmacol; 1980 May 05; 4(1):57-68. PubMed ID: 7403345 [No Abstract] [Full Text] [Related]
19. Dementia in Parkinson's disease and (pre) senile dementia of Alzheimer type: morphological aspects and changes in the intracerebral MAO activity. Jellinger K, Riederer P. Adv Neurol; 1984 May 05; 40():199-210. PubMed ID: 6695595 [No Abstract] [Full Text] [Related]
20. Monoamine oxidase activity during (--)-deprenil therapy: human brain post-mortem studies. Riederer P, Youdim MB, Birkmayer W, Jellinger K. Adv Biochem Psychopharmacol; 1978 May 05; 19():377-82. PubMed ID: 696465 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]